Erbe Cryo2
Payments companies reported to CMS as associated with Erbe Cryo2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbe Cryo2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbe Cryo2
These are the largest totals companies reported as associated with Erbe Cryo2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Aderajew Taddesse | Atlanta, GA | Pulmonary Disease | $96.11 |
| Jason Beattie | Boston, MA | Pulmonary Disease | $96.11 |
| Brian Rosenberg | Torrance, CA | Pulmonary Disease | $96.11 |
| Ernesto Casillas | San Francisco, CA | Pulmonary Disease | $96.11 |
| Mihir Parikh | Boston, MA | Internal Medicine | $96.11 |
| Kai Swenson | Boston, MA | Pulmonary Disease | $96.11 |
| Fahim Pyarali | Boston, MA | Pulmonary Disease | $96.11 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $96.11 |
| Huseyin Dincer | Minneapolis, MN | Pulmonary Disease | $70.48 |
| Abbie Begnaud | Minneapolis, MN | Pulmonary Disease | $70.48 |
Prescribed Erbe Cryo2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.